Doing our best to make it better
At Merck Serono, we focus on finding ways of responding to significant unmet medical needs.
We do this by bringing treatments and services to patients in the therapy areas we know best: oncology, neurodegenerative
diseases, fertility, endocrinology, cardiometabolic care and other specialist areas such as dermatology. Through groundbreaking
science and patient-friendly drug delivery systems, we help people live fuller and more satisfying lives.
Disclaimer
This section gives an overview of the UK’s Company's activities in our core Therapeutic Areas.
| Erbitux® | Rebif® |
| GONAL-f® | Saizen® |
| Serostim® | Raptiva® |
Today, there are still more diseases than there are treatments. Of the approximately 30,000 known diseases, effective treatments
are available for only about one third. In some cases, treatment options exist but are unsatisfactory due to poor efficacy
or unpleasant side effects.
Greater understanding of different diseases and their causes is helping to produce therapies that can more effectively address
medical needs. New insights into the biology of disease and more precise understanding of why some people react differently
lie at the heart of biotechnology.
Biotechnology holds the promise of more targeted treatments for individual groups of patients as well as finding treatments
for diseases that have so far eluded scientists. It also provides new opportunities to meet challenging but common diseases
like cancer and heart disease.
Innovating therapeutic solutions to successfully respond to unmet medical needs is Merck Serono’s number one priority.
